|
|
| | CRGDFPASSC Basic information |
| Product Name: | CRGDFPASSC | | Synonyms: | CYS-ARG-GLY-ASP-PHE-PRO-ALA-SER-SER-CYS;CRGDFPASSC;H-CYS-ARG-GLY-ASP-PHE-PRO-ALA-SER-SER-CYS-OH;H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH (Disulfide bond);L-Cysteine, L-cysteinyl-L-arginylglycyl-L-α-aspartyl-L-phenylalanyl-L-prolyl-L-alanyl-L-seryl-L-seryl-, cyclic (1→10)-disulfide (9CI);H-Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys-OH(Cys&Cys Bridge);Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge: Cys1-Cys10) | | CAS: | 166184-23-2 | | MF: | C41H61N13O15S2 | | MW: | 1040.13 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | CRGDFPASSC Chemical Properties |
| storage temp. | -15°C | | Sequence | Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10) |
| | CRGDFPASSC Usage And Synthesis |
| Uses | Cys-Arg-Gly-Asp-Phe-Pro-Ala-Ser-Ser-Cys (Disulfide bridge:cys1-cys10), a decapeptide containing a cyclic RGD active sequence, is an Integrin αIIbβ3 antagonist that inhibits platelet and Adhesion of proMMP-13[1]. |
| | CRGDFPASSC Preparation Products And Raw materials |
|